Cetuximab (PBS)
Cetuximab (PBS) is a human IgG1 monoclonal antibody that can inhibit EGFR. The SPR method measured the Kd value of Cetuximab for EGFR to be 0.201 nM; Cetuximab has a highly effective anti-tumor effect[1].
Product Specifications
UNSPSC
12352203
Target
EGFR; Radionuclide-Drug Conjugates (RDCs)
Related Pathways
Antibody-drug Conjugate/ADC Related; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.3
Smiles
[Cetuximab(PBS)]
Molecular Weight
(145.54 kDa)
References & Citations
[1]Goldstein, et al. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clinical cancer research: an official journal of the American Association for Cancer Research 1.11 (1995) : 1311-1318.|[2]Gustafsson H, et al. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model. Cell Biochem Biophys. 2017 Jul 29.|[3]Huang SM, et al. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res. 1999 Apr 15;59 (8) :1935-40.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GLM SKU0009 1 Piece
LunaGel - Bovine Bone, High Stiffness (0 - 25 kPa)
Sign In for Pricing
View Details 248483-ML490 100 µL
MAPK12 (Mitogen-Activated Protein Kinase 12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3) (MaxLight 490)
Sign In for Pricing
View Details 
